Product Information
- BI 207127
- (2E)-3-[2-[1-[[[2-(5-Bromo-2-pyrimidinyl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-2-propenoic acid
- 2-Propenoic acid, 3-[2-[1-[[[2-(5-bromo-2-pyrimidinyl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-, (2E)-
- (E)-3-[2-[1-[[[2-(5-Bromopyrimidin-2-yl)-3-cyclopentyl-1-methyl-1H-indol-6-yl]carbonyl]amino]cyclobutyl]-1-methyl-1H-benzimidazol-6-yl]-2-propenoic acid
Deleobuvir is a potent and selective inhibitor of the Kv1.3 voltage-gated potassium channel, which is activated in response to membrane depolarization. Deleobuvir inhibits the activation of this channel by blocking the binding of its activator peptide, Kv1.3-activating peptide (KAP). Deleobuvir has been shown to be effective in inhibiting the growth of cells that express this receptor, such as tumor cells.
Chemical properties
Technical inquiry about: 3D-NJB88477 Deleobuvir
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.